Adhesion of bacteria and of metastasizing tumour cells have much in co
mmon, especially the participation of lectins in this process. In the
future it might be possible to inhibit the metastatic process and bact
erial adhesion by blocking with lectins specific for appropriate (olig
o) saccharides or glycoconjugates. Initial clinical trials are very pr
omising.